Volume 7, Issue 2, Pages (August 1997)

Slides:



Advertisements
Similar presentations
Figure 2. Positive selection of J15 TCR transgenic T cells specific for H60. (A) CD4 by CD8 profiles (left) of thymocytes and numbers (right) of each thymic.
Advertisements

Volume 17, Issue 9, Pages (November 2016)
Volume 6, Issue 4, Pages (April 1997)
Pancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Volume 18, Issue 5, Pages (May 2003)
Volume 7, Issue 4, Pages (October 1997)
Volume 7, Issue 8, Pages (August 2000)
Volume 5, Issue 1, Pages (July 1996)
Proteomic Approaches to Cancer Biomarkers
The Roles of Fas/APO-1 (CD95) and TNF in Antigen-Induced Programmed Cell Death in T Cell Receptor Transgenic Mice  Huey-Kang Sytwu, Roland S Liblau, Hugh.
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Volume 7, Issue 11, Pages (November 2000)
Correlating Notch Signaling with Thymocyte Maturation
Volume 5, Issue 2, Pages (August 1996)
Volume 4, Issue 1, Pages (January 1996)
Volume 16, Issue 6, Pages (June 2002)
Volume 7, Issue 2, Pages (August 1997)
Ananda W Goldrath, Michael J Bevan  Immunity 
TIGIT expression in naive T cells is accelerated by coculture with si-tolerant T cells at an early-stimulation stage. TIGIT expression in naive T cells.
Volume 28, Issue 1, Pages (January 2008)
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Volume 41, Issue 2, Pages (August 2014)
Volume 21, Issue 5, Pages (November 2004)
A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells  Aixin Yu, Linjian Zhu, Norman H. Altman,
Highly Efficient Selection of CD4 and CD8 Lineage Thymocytes Supports an Instructive Model of Lineage Commitment  Andrea Itano, Ellen Robey  Immunity 
Designing and Maintaining the Mature TCR Repertoire
Posttranslational Regulation of Ca2+-Activated K+ Currents by a Target-Derived Factor in Developing Parasympathetic Neurons  Priya Subramony, Sanja Raucher,
Targeted Complementation of MHC Class II Deficiency by Intrathymic Delivery of Recombinant Adenoviruses  Ronald Rooke, Caroline Waltzinger, Christophe.
Volume 6, Issue 3, Pages (March 1997)
Volume 17, Issue 2, Pages (August 2002)
Unexpectedly Complex Regulation of CD4/CD8 Coreceptor Expression Supports a Revised Model for CD4+CD8+ Thymocyte Differentiation  Bruno Lucas, Ronald.
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
Volume 7, Issue 4, Pages (October 1997)
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Lck Activity Controls CD4/CD8 T Cell Lineage Commitment
Differential Roles of ERK and p38 MAP Kinase Pathways in Positive and Negative Selection of T Lymphocytes  Takehiko Sugawara, Tetsuo Moriguchi, Eisuke.
Volume 18, Issue 3, Pages (March 2003)
A Molecular Map of T Cell Development
Susan V Outram, Alberto Varas, Carmen V Pepicelli, Tessa Crompton 
Peter A. Savage, Mark M. Davis  Immunity 
Volume 7, Issue 8, Pages (August 2000)
Volume 13, Issue 6, Pages (December 2000)
The CD8α Gene Locus Is Regulated by the Ikaros Family of Proteins
Volume 11, Issue 2, Pages (August 1999)
Shotgun Proteomics in Neuroscience
Volume 27, Issue 5, Pages (November 2007)
Volume 16, Issue 5, Pages (May 2002)
Volume 36, Issue 6, Pages (June 2012)
Volume 17, Issue 2, Pages (August 2002)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Cécile Bouneaud, Philippe Kourilsky, Philippe Bousso  Immunity 
Volume 6, Issue 3, Pages (March 1997)
Volume 12, Issue 5, Pages (May 2000)
The Shaping of the T Cell Repertoire
Kai M Müller, Carrie J Luedecker, Mark C Udey, Andrew G Farr  Immunity 
Volume 29, Issue 5, Pages (November 2008)
Intrathymic T Cell Development and Selection Proceeds Normally in the Absence of Glucocorticoid Receptor Signaling  Jared F Purton, Richard L Boyd, Timothy.
Volume 14, Issue 3, Pages (March 2001)
Volume 11, Issue 12, Pages (June 2001)
Volume 16, Issue 6, Pages (June 2002)
Volume 17, Issue 9, Pages (November 2016)
Volume 7, Issue 2, Pages (August 1997)
Volume 25, Issue 1, Pages (July 2006)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 9, Issue 2, Pages (August 1998)
RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T Cells  You-Wen He, Michael L Deftos,
Interaction of the NK Cell Inhibitory Receptor Ly49A with H-2Dd
The Influence of the MAPK Pathway on T Cell Lineage Commitment
Generation of Functional Thymocytes in the Human Adult
Presentation transcript:

Volume 7, Issue 2, Pages 221-231 (August 1997) Specific Recognition of Thymic Self-Peptides Induces the Positive Selection of Cytotoxic T Lymphocytes  Qinghui Hu, Carthene R Bazemore Walker, Cristina Girao, Joseph T Opferman, Jiling Sun, Jeffery Shabanowitz, Donald F Hunt, Philip G Ashton-Rickardt  Immunity  Volume 7, Issue 2, Pages 221-231 (August 1997) DOI: 10.1016/S1074-7613(00)80525-7

Figure 1 Chromatography of Peptides Eluted from H-2Db Molecules of 427.1 Cells Peptides from anti-H-2Db affinity columns (H-2Db) or mock extracts (H-2Dd) were resolved by C18 narrow-bore RP-HPLC. Peptides in RP-HPLC fractions from peaks unique to H-2Db chromatographs (arrows; asterisk, pooled fractions 37 and 38) were further analyzed. Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 2 Purification of H-2Db–Associated Self-Peptides from 427.1 Cells (A and B) Plots of total ion current obtained in each mass spectrum recorded on 1/25 of the material in the pooled RP-HPLC fractions 37 and 38 from anti-H-2Db (A) and anti-H-2Dd mock extracts (B). Mass spectra were recorded on a triple-quadrupole mass spectrometer equipped with an electrospray ion source and a C-18 microcapillary-HPLC column. The mass range, m/z 300–1400, was scanned repetitively every 1.5 sec, and the total ion signal in each spectrum was summed. Insets are plots of the ion current for the peptide (M+2H)2+ at m/z 541 (nominal mass). (C) Collision-activated dissociation mass spectrum of peptide (M+2H)2+ ions at m/z 541. Predicted masses for fragment ions of types b and y are shown above and below the deduced amino acid sequence (Hunt et al. 1986). Ions observed in the spectrum are underlined. Subtraction of m/z values for any two fragments that differ by a single amino acid generates a value that specifies the mass and thus the identity of the extra residue in the larger fragment. Since isoleucine and leucine are of identical mass, they cannot be differentiated on the triple-quadrupole instrument and are specified as Lxx. O indicates ions that represent single losses of water. Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 2 Purification of H-2Db–Associated Self-Peptides from 427.1 Cells (A and B) Plots of total ion current obtained in each mass spectrum recorded on 1/25 of the material in the pooled RP-HPLC fractions 37 and 38 from anti-H-2Db (A) and anti-H-2Dd mock extracts (B). Mass spectra were recorded on a triple-quadrupole mass spectrometer equipped with an electrospray ion source and a C-18 microcapillary-HPLC column. The mass range, m/z 300–1400, was scanned repetitively every 1.5 sec, and the total ion signal in each spectrum was summed. Insets are plots of the ion current for the peptide (M+2H)2+ at m/z 541 (nominal mass). (C) Collision-activated dissociation mass spectrum of peptide (M+2H)2+ ions at m/z 541. Predicted masses for fragment ions of types b and y are shown above and below the deduced amino acid sequence (Hunt et al. 1986). Ions observed in the spectrum are underlined. Subtraction of m/z values for any two fragments that differ by a single amino acid generates a value that specifies the mass and thus the identity of the extra residue in the larger fragment. Since isoleucine and leucine are of identical mass, they cannot be differentiated on the triple-quadrupole instrument and are specified as Lxx. O indicates ions that represent single losses of water. Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 3 Some but Not All Self-Peptides Induce the Positive Selection of CD8+ Cells The ability of thymic self-peptides (HH, BP, and RR) to restore the positive selection of CD8+ cells was tested in TAP1− FTOC. Thymocytes from TAP1+ and TAP1− FTOC were analyzed for the surface expression of CD8, CD4, and pan-TCRβ chain by MAb staining and FACS. Thymocytes that were CD4−CD8+ were gated and analyzed for the surface expression of pan-TCRβ, and then the overall percentage of CD4−CD8+ TCR+hi cells was determined (CD8+ cells). The levels indicated are based on the analysis of three to five separately cultured lobes (mean ± SEM). Addition of either HH or BP (300 μM) did not result in significant changes in the number of CD8+ cells (p > 5%) but the addition of RR (300 μM) did (1% > p > 0.5%). Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 4 Addition of Self-Peptides to TAP1− FTOC Restores the Positive Selection of Transgenic CD8+ Thymocytes (A) The positive selection of CD8+ F5 cells is impaired in fetal thymi from F5 TAP1− mice. Thymocytes from F5 TAP1+ and F5 TAP1− FTOC were analyzed for the surface expression of CD8, CD4 and TCR Vβ11 by MAb staining and FACS. Thymocytes that were CD4−CD8+ were gated and analyzed for the surface expression of TCR Vβ11, and then the overall percentage of CD4− CD8+ TCR Vβ11+hi (CD8+ F5 cells) was determined. The percentage of CD8+ F5 cells was reduced in F5 TAP1− (1%) compared to F5 TAP1+ (21%) FTOC. The percentage of CD8+ F5 cells could be partially restored by the addition of HH (3%) and BP (6%) peptides at 300 μM to F5 TAP1− FTOC. Similar results were obtained in four other separately performed experiments. (B) The positive selection of CD8+ P14 cells is impaired in fetal thymi from P14 TAP1− mice. Thymocytes from P14 TAP1+ and P14 TAP1− FTOC were analyzed for the surface expression of CD8, CD4, TCR Vα2, and TCR Vβ8.1 by MAb staining and FACS. Thymocytes that were CD4−CD8+ were gated and analyzed for the surface expression of TCR Vα2 and TCR Vβ8.1, and then the overall percentage of CD4−CD8+ TCR Vα2+hi TCR Vβ8.1+hi (CD8+ P14 cells) was determined. The percentage of CD8+ P14 cells was reduced in P14 TAP1− (1%) compared to P14 TAP1+(15%) FTOC and could be partially restored by the addition of the RR peptide (3%) at 300 μM. Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 5 Differential Ability of Self-Peptides to Induce the Positive Selection of Transgenic CD8+ Thymocytes (A) The ability of thymic self-peptides (HH, BP, and RR) to restore the positive selection of CD8+ F5 cells was tested in F5 TAP1− FTOC, when added at 300 μM. The peptides BP (5% > p > 1%) and HH (5% > p > 1%) but not RR (p > 5%) were capable of generating CD8+ F5 cells above the level of F5 TAP1− FTOC incubated alone. There was no significant difference between the abilities of HH and BP to induce the positive selection of CD8+ F5 cells (p > 5%). (B) The ability of thymic self-peptides to restore the positive selection of CD8+ P14 cells was tested in P14 TAP1− FTOC when added at 300 μM. RR gave rise to numbers of CD8+ P14 cells above the level of P14 TAP1− FTOC incubated alone (1% > p > 0.5%), but HH (p > 5%) and BP (p > 5%) did not. The data represent the mean ± SEM of values obtained from four to six independently cultured thymi. Similar results were obtained in six other experiments. Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)

Figure 6 Summary of Self-Peptide Selection Experiments (A) The ability of thymic self-peptides (HH, BP, and RR) to restore the positive selection of CD8+ F5 cells was tested in F5 TAP1− FTOC, when added at 300 μM. Each point represents the mean number of CD8+ F5 cells recovered from thymic lobes from five separate experiments (four to six independent lobes per experiment, as in Figure 4 and Figure 5). The mean value for cell number is indicated with the SEM. The peptides BP (p < 0.1%) and HH (0.2% > p > 0.1%) but not RR (p > 5%) were capable of generating CD8+ F5 cells above the level of F5 TAP1− FTOC incubated alone. There was no significant difference between the abilities of HH and BP to induce the positive selection of CD8+ F5 cells (p > 5%). The number of CD8+ F5 cells recovered from F5 TAP1+ FTOC ranged from 16 to 59 × 103 cells per lobe (six experiments). (B) The ability of thymic self-peptides to restore the positive selection of CD8+ P14 cells was tested in P14 TAP1− FTOC, when added at 300 μM, over the course of seven separate experiments (as in A). RR gave rise to numbers of CD8+ P14 cells above the level of P14 TAP1− FTOC incubated alone (1% > p > 0.5%), but HH (p > 5%) and BP (p > 5%) did not. The number of CD8+ P14 cells recovered from P14 TAP1+ FTOC ranged from 17 to 60 × 103 cells per lobe (seven experiments). Immunity 1997 7, 221-231DOI: (10.1016/S1074-7613(00)80525-7)